RFK Jr.’s FDA Slams Door on COVID Vaccine

In a move that’s sparking outrage and praise across the political spectrum, the Biden-appointed-but-now-Trump-endorsed Health Secretary Robert F. Kennedy Jr. has overseen one of the most drastic COVID vaccine restrictions since the pandemic began. The FDA, under his leadership, just approved the Novavax vaccine—but only for a narrow group of Americans.

The message is loud and clear: If you’re healthy and under 65, don’t expect a jab.

According to the FDA’s latest guidance, the Novavax shot is now reserved only for adults and children over 12 who suffer from a serious medical condition that makes them vulnerable to severe COVID. That means the average American, even those trying to protect an elderly parent or immunocompromised spouse, is out of luck.

“We’re finally seeing a return to personal medical responsibility,” one senior HHS official said privately. “The days of blank-check pharmaceutical approvals are over.”

Background:
For years, Novavax was pitched as a protein-based alternative to the mRNA shots developed by Pfizer and Moderna. Unlike those vaccines—which were rushed through under emergency authorizations—Novavax took four years of trials before earning full FDA approval. Yet now that approval comes with a catch: strict limits on who can receive it.

The Centers for Disease Control and Prevention (CDC) had been wrestling with whether to scale back COVID shot recommendations. This new FDA action has all but settled the debate.

But not everyone’s happy. Critics—especially legacy medical insiders tied to the old CDC leadership—are calling the move “dangerous.”

Dr. Camille Kotton, an infectious disease specialist and former CDC adviser, sounded the alarm in The New York Times:

“This is a dark day in American medicine,” she said.
“I don’t know why they would make this restriction. I don’t know of any indication to make this change.”

Kotton, who works at Massachusetts General Hospital, suggested the decision could leave certain vulnerable groups unprotected if a new COVID variant emerges.

But Kennedy isn’t backing down.
The longtime vaccine skeptic—now at the helm of U.S. health policy—has already launched a full review of vaccine safety protocols, including long-dismissed concerns about links between vaccines and autism. Critics call it dangerous. His supporters call it long overdue.

“Americans have the right to question Big Pharma,” Kennedy said during a recent House hearing on the 2026 health budget. “Transparency and accountability should be the cornerstone of public health.”

Even as Pfizer and Moderna scramble to roll out new boosters for the fall, the FDA’s stance signals a broader philosophical shift: vaccines aren’t for everyone anymore. At least not without a medical reason.

What This Means for You:
If you’re under 65 and healthy, you won’t be able to get the Novavax vaccine—even if you want to. That’s a big change from the one-size-fits-all vaccine policy of 2021–2023.

And with COVID fading from daily headlines but still lurking in headlines about future variants, Kennedy’s team is betting on a new approach: protect the vulnerable, but leave the rest alone.

For some, it’s a sign of government finally stepping back. For others, it’s a warning shot.

Either way, RFK Jr. just rewrote the rules on COVID vaccines—and he’s not apologizing for it.